MALARIA CONSORTIUM

Registered charity 1099776 · accounts filings on the Charity Commission register

Prevention, diagnosis and treatment of malaria and communicable diseasesReaching vulnerable and hard to reach populationsHealth systems strengthening and capacityChildhood illnessesMap Neglected Tropical Diseases Operational research Monitoring and EvaluationAdvocacy and communication

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · The Prevention Or Relief Of Poverty · Overseas Aid/famine Relief · website · Get email alerts

Latest income
£72.2m
Latest spending
£69.2m
Registered
2003
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that total income decreased by 18 percent to £72.2 million, resulting in an unrestricted surplus of £3.02 million. Unrestricted reserves rose to £34.3 million, which is temporarily above the new risk-based target range of £21 million to £28 million. The charity maintains a healthy cash position with significant deferred income from donors for future activities.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: £21 million to £28 million (held: £34.3m)
“Under this approach, the target range for general reserves is £21 million to £28 million, representing about 9–12 months of risk-weighted expenditure.”
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Aggregate donations from trustees.
“Aggregate donations from trustees during the year ended 31 March 2025 amounted to £1,000 (2024: £nil).” — page 59
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Buzzacott Audit LLP. Discloses 4 of 6 completeness components.

In the news

Recent coverage mentioning this charity by name (automated match; headlines belong to their publishers).

Corporate structure

Public fundraising profile: JustGiving — Malaria Consortium (matched by registered charity number).

Company officers (Companies House)

Current officers of the charity’s own company per the Companies House register, cross-checked against the Charity Commission trustee list by name. A director not on the trustee list is usually a timing or naming difference between the two registers — check both records before drawing conclusions.

Official officers record.

UK research funding (UKRI Gateway to Research)

Structured financials (annual return, FY ending 31/03/2025)

Total income
£72.2m
Total spending
£69.2m
Cost of raising funds
£509k
Reserves (reported)
£34.3m
Employees
618

Reported reserves equal ~5.9 months of spending — above the median for charities its size (median 4.6 months; benchmarks).

Per its annual return, largest income source: Charitable activities (92% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 0.7% of total income — below the median for charities its size (3.8%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Burkina Faso · Burma · Cambodia · Chad · City Of London · Ethiopia · Mozambique · Nigeria · South Sudan · Thailand · Uganda

Income and spending

Financial year endIncomeSpending
31/03/2025£72.2m£69.2m
31/03/2024£88.6m£74.1m
31/03/2023£100.7m£94.7m
31/03/2022£84.4m£79.8m
31/03/2021£68.1m£66.8m

Common questions

Is MALARIA CONSORTIUM financially healthy?

Per its FY2025 accounts: The accounts state that total income decreased by 18 percent to £72.2 million, resulting in an unrestricted surplus of £3.02 million. Unrestricted reserves rose to £34.3 million, which is temporarily above the new risk-based target range of £21 million to £28 million. The charity maintains a healthy cash position with significant deferred income from donors for future activities. Its FY2025 accounts were audited by Buzzacott Audit LLP.

Who funds MALARIA CONSORTIUM?

Funders whose own accounts filings name MALARIA CONSORTIUM as a grant recipient include EFFECTIVE VENTURES FOUNDATION, THE CYNARA FOUNDATION, JAMES PERCY FOUNDATION, THE BLYTH WATSON CHARITABLE TRUST.

Known funders

Grants to this charity found in funders’ own accounts filings.

FunderYearAmountPurpose (as stated by the funder)
EFFECTIVE VENTURES FOUNDATIONFY2022£820k
EFFECTIVE VENTURES FOUNDATIONFY2024£510k
THE CYNARA FOUNDATIONFY2022£500k
JAMES PERCY FOUNDATIONFY2023£406kEthiopia
JAMES PERCY FOUNDATIONFY2022£161kStrengthening community-based malaria prevention and surveillance interventions, SNNPR, Ethiopia
EFFECTIVE VENTURES FOUNDATIONFY2025£52k
THE CYNARA FOUNDATIONFY2023£40k
THE CYNARA FOUNDATIONFY2024£25k
THE BLYTH WATSON CHARITABLE TRUSTFY2024£1k
THE BLYTH WATSON CHARITABLE TRUSTFY2023£1k
JAMES PERCY FOUNDATIONFY2021£0Strengthening community-based malaria prevention and surveillance interventions
THE BLYTH WATSON CHARITABLE TRUSTFY2025£0

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with THE AGAINST MALARIA FOUNDATION.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
MALARIA CONSORTIUM£72.2m——above—no doubt
THE AGAINST MALARIA FOUNDATION FY2025£113.9m——above—no doubt
Mikuyu Tanzania FY2025£240k—0unclear10.8%no doubt
SAVING LIVES FY2025£401k—0unclear—no doubt
REACHING THE UNREACHED FY2025£773k—0unclear—no doubt
MWL NHS Charity FY2025£321k—0within—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.